Luye Pharma Group
Zhigang Sun is a seasoned pharmaceutical professional currently serving as Group Senior Vice President at Luye Pharma Group since September 2018, overseeing international R&D for new drugs, biologics, gene therapy, quality assurance, global regulatory affairs, and pharmacovigilance. Prior to this, Zhigang held the position of Vice President of Regulatory Affairs at SUN PHARMA from August 2017 to September 2018. Experience also includes serving as Acting Branch Chief at the FDA's Office of Process & Facilities from June 2014 to August 2017, where responsibilities encompassed integrated process review and facility inspection, along with acting roles in CMC review and site leadership. Early career highlights include being a Senior Development Scientist at Malvern Instruments, focusing on process analytical technology and particle characterization. Zhigang Sun earned a Ph.D. in Chemical Engineering from Purdue University.
This person is not in any teams
This person is not in any offices
Luye Pharma Group
2 followers
Luye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has established R&D centers in China, the U.S. and Europe, with a robust pipeline of 40 drug candidates in China and more than 10 drug candidates overseas.